BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16882195)

  • 1. Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis.
    Cuétara MS; Aguilar A; Martin L; Aspiroz C; del Palacio A
    Br J Dermatol; 2006 Aug; 155(2):477-9. PubMed ID: 16882195
    [No Abstract]   [Full Text] [Related]  

  • 2. Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab.
    Bragg J; Pomeranz MK
    Dermatol Online J; 2007 Jan; 13(1):1. PubMed ID: 17511934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous side effects of EGF receptor inhibitors].
    Nassar D; Soutou B; Aractingi S
    Bull Cancer; 2009 Dec; 96 Suppl():S85-91. PubMed ID: 20034874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malassezia folliculitis presented as acneiform eruption after cetuximab administration.
    Cholongitas E; Pipili C; Ioannidou D
    J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Trametinib-Associated Folliculitis Eruption With Fluconazole.
    Steele C; Gershon T; Burkhart C; Googe P
    JAMA Dermatol; 2020 Jun; 156(6):706-708. PubMed ID: 32267472
    [No Abstract]   [Full Text] [Related]  

  • 6. Dimorphic cutaneous manifestation of a toxic eruption due to erlotinib therapy.
    Campbell TM; Brown CW
    J Drugs Dermatol; 2008 Dec; 7(12):1161-3. PubMed ID: 19137770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal folliculitis masquerading as acute exanthematous pustulosis.
    Sharma T; Vij A; Sood A
    Cleve Clin J Med; 2016 Mar; 83(3):179-80. PubMed ID: 26974987
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of gefitinib-associated folliculitis.
    Matheis P; Socinski MA; Burkhart C; Warren S; Thomas NE
    J Am Acad Dermatol; 2006 Oct; 55(4):710-3. PubMed ID: 17010757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How important is the pus culture obtained from epithelial growth factor receptor (EGFR) inhibitors' associated rash?
    Cholongitas E; Kokolakis G; Ioannidou D
    Int J Dermatol; 2008 Nov; 47(11):1203-4. PubMed ID: 18986464
    [No Abstract]   [Full Text] [Related]  

  • 10. Erlotinib-induced scalp perifolliculitis.
    Rallis E; Petronic-Rosic V; Korfitis C
    Skinmed; 2012; 10(2):70-1. PubMed ID: 22545319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tufted hair folliculitis in a woman treated with lapatinib for breast cancer.
    Ena P; Fadda GM; Ena L; Farris A; Santeufemia DA
    Clin Exp Dermatol; 2008 Nov; 33(6):790-1. PubMed ID: 18627387
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse reactions to gefitinib (Iressa): revealing sycosis- and pyoderma gangrenosum-like lesions.
    Sagara R; Kitami A; Nakada T; Iijima M
    Int J Dermatol; 2006 Aug; 45(8):1002-3. PubMed ID: 16911406
    [No Abstract]   [Full Text] [Related]  

  • 13. Follicular variant of seborrheic dermatitis: is it identical to Malassezia folliculitis?
    Valentine MC
    Skinmed; 2011; 9(3):161-6. PubMed ID: 21675495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malassezia folliculitis: 21 cases].
    Masmoudi A; Ben Salah H; Makni F; Chikrouhou F; Boudaya S; Ayadi A; Turki H
    Ann Dermatol Venereol; 2010 Apr; 137(4):305-6. PubMed ID: 20417367
    [No Abstract]   [Full Text] [Related]  

  • 15. Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis.
    Lee JW; Kim BJ; Kim MN
    Lasers Surg Med; 2010 Feb; 42(2):192-6. PubMed ID: 20166153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel presentation of immune reconstitution inflammatory syndrome: folliculitis secondary to Malassezia spp.
    Moreno-Coutiño G; Espinosa E; Garcia-Romero MT; Reyes-Terán G
    Mycoses; 2011 Jul; 54(4):e252-4. PubMed ID: 20202115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare cutaneous side-effect of gefitinib masquerading as superficial dermatophytosis.
    Lin SS; Tsai TH; Yang HH
    Clin Exp Dermatol; 2009 Jun; 34(4):528-30. PubMed ID: 19196304
    [No Abstract]   [Full Text] [Related]  

  • 18. Erlotinib-induced skin manifestations.
    Motoki T; Mitsuishi T; Kawana S
    J Dermatol; 2009 Dec; 36(12):658-9. PubMed ID: 19958452
    [No Abstract]   [Full Text] [Related]  

  • 19. Erlotinib-induced dermatologic side-effects.
    Bovenschen HJ; Alkemade JA
    Int J Dermatol; 2009 Mar; 48(3):326-8. PubMed ID: 19261029
    [No Abstract]   [Full Text] [Related]  

  • 20. Necrotizing Infundibular Crystalline Folliculitis (NICF) Induced by Anti-Tumoral Therapies: Report of 2 Cases.
    Fattouh K; Collet-Benzaquen D; Provensal AM; Desseigne F; Castillo C; Combemale P; de la Fouchardière A
    Am J Dermatopathol; 2017 Oct; 39(10):764-766. PubMed ID: 27779486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.